AbbVie As Patent Enemy: Suit vs. MedImmune Aims To Halt Humira Royalty
This article was originally published in The Pink Sheet Daily
Executive Summary
Latest legal battle over Humira centers around validity of patent covered in 1995 license agreement between predecessor firms.